AAAAAA

   
Results: 1-25 | 26-50 | 51-66
Results: 1-25/66

Authors: NEWMAN MEJ ENGELHARDT R
Citation: Mej. Newman et R. Engelhardt, EFFECTS OF SELECTIVE NEUTRALITY ON THE EVOLUTION OF MOLECULAR-SPECIES, Proceedings - Royal Society. Biological Sciences, 265(1403), 1998, pp. 1333-1338

Authors: BRUGGER W DIERKESMANN R TOOMES H ENGELHARDT R HASSE J PRESSLER K KOLLMANNSBERGER C SCHUMACHER M FROMMHOLD H BAMBERG M KANZ L
Citation: W. Brugger et al., MULTICENTER RANDOMIZED PHASE-III STUDY EVALUATING THE ROLE OF HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER, Onkologie, 21, 1998, pp. 12-14

Authors: BRUGGER W FETSCHER S HASSE J FROMMHOLD H PRESSLER K MERTELSMANN R ENGELHARDT R KANZ L
Citation: W. Brugger et al., MULTIMODALITY TREATMENT INCLUDING EARLY HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER, Seminars in oncology, 25(1), 1998, pp. 42-48

Authors: ENGELHARDT R
Citation: R. Engelhardt, VERY LITTLE MONEY YIELDS VERY LITTLE - HO FMANN,RAINER OF HAMBURG DEVELOPS SURVIVAL STRATEGIES FOR THE ORTHOPEDIC PRACTICE, Zeitschrift fur Orthopadie und Ihre Grenzgebiete, 136(2), 1998, pp. 16-17

Authors: STEHR K CHERRY JD HEININGER U SCHMITTGROHE S UBERALL M LAUSSUCQ S ECKHARDT T MEYER M ENGELHARDT R CHRISTENSON P
Citation: K. Stehr et al., A COMPARATIVE EFFICACY TRIAL IN GERMANY IN INFANTS WHO RECEIVED EITHER THE LEDERLE TAKEDA ACELLULAR PERTUSSIS COMPONENT DTP (DTAP) VACCINE,THE LEDERLE WHOLE-CELL COMPONENT DTP VACCINE, OR DT VACCINE/, Pediatrics, 101(1), 1998, pp. 1-11

Authors: ENGELHARDT R TURCK V POHL UW BIMBERG D VEIT P
Citation: R. Engelhardt et al., 3-DIMENSIONALLY CONFINED EXCITONS IN MOCVD-GROWN ULTRATHIN CDSE DEPOSITIONS IN ZNSSE MATRIX, Journal of crystal growth, 185, 1998, pp. 311-314

Authors: KUTTLER M STRASSBURG M TURCK V ENGELHARDT R POHL UW BIMBERG D BEHRINGER M HOMMEL D NURNBERGER J LANDWEHR G
Citation: M. Kuttler et al., EFFICIENT LATERAL INDEX GUIDING OF II-VI LASER STRUCTURES BY IMPLANTATION-INDUCED DISORDERING, Journal of crystal growth, 185, 1998, pp. 566-570

Authors: ENGELHARDT R
Citation: R. Engelhardt, BONE-MARROW BIOPSY IN ANEMIA, Deutsche Medizinische Wochenschrift, 122(15), 1997, pp. 493-493

Authors: FETSCHER S FINKE J ENGELHARDT R MERTELSMANN R LANGE W
Citation: S. Fetscher et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH 2ND PRIMARY MALIGNANCIES, HEM CELL TH, 39(2), 1997, pp. 79-83

Authors: KOOP N BRINKMANN R LANKENAU E FLACHE S ENGELHARDT R BIRNGRUBER R
Citation: N. Koop et al., OPTICAL COHERENCE TOMOGRAPHY OF CORNEA AN D ANTERIOR SEGMENT OF THE EYE, Der Ophthalmologe, 94(7), 1997, pp. 481-486

Authors: ASIYOVOGEL MN KOOP N BRINKMANN R ENGELHARDT R EGGERS R BIRNGRUBER R VOGEL A
Citation: Mn. Asiyovogel et al., EVALUATION OF LTK LESIONS BY OPTICAL LOW- COHERENCE TOMOGRAPHY (OCT) AND POLARIZATION MICROSCOPY AFTER SIRIUS-RED STAINING, Der Ophthalmologe, 94(7), 1997, pp. 487-491

Authors: FETSCHER S FINKE J ENGELHARDT R MERTELSMANN R LANGE W
Citation: S. Fetscher et al., EARLY-ONSET SECONDARY MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Annals of hematology, 74(2), 1997, pp. 73-77

Authors: BURGER JA OCHS A WIRTH K BERGER DP MERTELSMANN R ENGELHARDT R ROESSLE M HAAG K
Citation: Ja. Burger et al., THE TRANSJUGULAR STENT IMPLANTATION FOR THE TREATMENT OF MALIGNANT PORTAL AND HEPATIC VEIN OBSTRUCTION IN CANCER-PATIENTS, Annals of oncology, 8(2), 1997, pp. 200-202

Authors: FETSCHER S BRUGGER W ENGELHARDT R KANZ L HASSE J FROMMHOLD H WENGER M LANGE W MERTELSMANN R
Citation: S. Fetscher et al., DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 100 CONSECUTIVE PATIENTS WITH, LIMITED-DISEASE AND EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER, Annals of oncology, 8(1), 1997, pp. 49-56

Authors: FETSCHER S BRUGGER W ENGELHARDT R KANZ L HASSE J FROMMHOLD H WENGER M LANGE W MERTELSMANN R
Citation: S. Fetscher et al., DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 107 CONSECUTIVE PATIENTS WITH, LIMITED-STAGE AND EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 8(1), 1997, pp. 57-64

Authors: METENS S DEWEL G BORCKMANS P ENGELHARDT R
Citation: S. Metens et al., PATTERN SELECTION IN BISTABLE SYSTEMS, Europhysics letters, 37(2), 1997, pp. 109-114

Authors: WELZEL J LANKENAU E BIRNGRUBER R ENGELHARDT R
Citation: J. Welzel et al., OPTICAL COHERENCE TOMOGRAPHY OF THE HUMAN SKIN, Journal of the American Academy of Dermatology, 37(6), 1997, pp. 958-963

Authors: DADGAR A ENGELHARDT R KUTTLER M BIMBERG D
Citation: A. Dadgar et al., CAPACITANCE TRANSIENT STUDY OF THE DEEP FE ACCEPTOR IN INDIUM-PHOSPHIDE, Physical review. B, Condensed matter, 56(16), 1997, pp. 10241-10248

Authors: BRINKMANN R KOOP N KAMPMEIER J BRUHNS A ASIYOVOGEL M ENGELHARDT R BIRNGRUBER R
Citation: R. Brinkmann et al., CORNEAL COLLAGEN DENATURATION IN LASER THERMOKERATOPLASTY (LTK), Investigative ophthalmology & visual science, 38(4), 1997, pp. 2514-2514

Authors: ENGELHARDT R
Citation: R. Engelhardt, PERSONA-NON-GRATA, Zeitschrift fur Orthopadie und Ihre Grenzgebiete, 135(5), 1997, pp. 1-1

Authors: ENGELHARDT R
Citation: R. Engelhardt, INTERVIEW WITH RAPPLE,THILO, Zeitschrift fur Orthopadie und Ihre Grenzgebiete, 135(3), 1997, pp. 14-15

Authors: ENGELHARDT R
Citation: R. Engelhardt, EVERYTHING MUST BE IN MOTION, Zeitschrift fur Orthopadie und Ihre Grenzgebiete, 135(3), 1997, pp. 16-17

Authors: ENGELHARDT R
Citation: R. Engelhardt, SPRING IN MAGDEBURG, Zeitschrift fur Orthopadie und Ihre Grenzgebiete, 135(2), 1997, pp. 14-15

Authors: ENGELHARDT R
Citation: R. Engelhardt, WORK IS ITS OWN REWARD, Zeitschrift fur Orthopadie und Ihre Grenzgebiete, 135(1), 1997, pp. 18-19

Authors: KIANI A TSCHIERSCH A GABORIAU E OTTO F SEIZ A KNOPF HP STUTZ P FARBER L HAUS U GALANOS C MERTELSMANN P ENGELHARDT R
Citation: A. Kiani et al., DOWN-REGULATION OF THE PROINFLAMMATORY CYTOKINE RESPONSE TO ENDOTOXINBY PRETREATMENT WITH THE NONTOXIC LIPID-A ANALOG-SDZ-MRL-953 IN CANCER-PATIENTS, Blood, 90(4), 1997, pp. 1673-1683
Risultati: 1-25 | 26-50 | 51-66